Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
International Journal of Clinical Oncology
|
June 24, 2017
Targeting DNA repair and replication stress in the treatment of ovarian cancer
Junko Murai
Cancer Research
|
May 17, 2019
Phosphatase 1 Nuclear Targeting Subunit, a Novel DNA Repair Partner of PARP1
Junko Murai, Yves Pommier
Cancer Science
|
June 29, 2022
Reconsidering the mechanisms of action of PARP inhibitors based on clinical outcomes
Hiroshi Onji, Junko Murai
Cancer Research
|
April 14, 2023
BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality
Junko Murai, Yves Pommier
The Journal of Clinical Investigation
|
April 18, 2018
The evolving landscape of predictive biomarkers of response to PARP inhibitors
Anish Thomas, Junko Murai, Yves Pommier
Cancer Treatment Reviews
|
October 1, 2018
Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition
Brittany Haynes, Junko Murai, Jung-Min Lee
Clinical Calcium
|
December 4, 2004
[Role of BMPs and Smads during endochondral bone formation]
Noriyuki Tsumaki, Mitsuru Horiki, Junko Murai, et al.
Pharmacology & Therapeutics
|
May 26, 2019
Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies
Junko Murai, Anish Thomas, Markku Miettinen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 31, 2020
Response to Letter to the Editor by Yang et al
Raffit Hassan, Manjistha Sengupta, Junko Murai, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 4, 2006
Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development
Mina Okamoto, Junko Murai, Hideki Yoshikawa, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
International Journal of Clinical Oncology
|
June 24, 2017
Targeting DNA repair and replication stress in the treatment of ovarian cancer
Junko Murai
Cancer Research
|
May 17, 2019
Phosphatase 1 Nuclear Targeting Subunit, a Novel DNA Repair Partner of PARP1
Junko Murai, Yves Pommier
Cancer Science
|
June 29, 2022
Reconsidering the mechanisms of action of PARP inhibitors based on clinical outcomes
Hiroshi Onji, Junko Murai
Cancer Research
|
April 14, 2023
BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality
Junko Murai, Yves Pommier
The Journal of Clinical Investigation
|
April 18, 2018
The evolving landscape of predictive biomarkers of response to PARP inhibitors
Anish Thomas, Junko Murai, Yves Pommier
Cancer Treatment Reviews
|
October 1, 2018
Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition
Brittany Haynes, Junko Murai, Jung-Min Lee
Clinical Calcium
|
December 4, 2004
[Role of BMPs and Smads during endochondral bone formation]
Noriyuki Tsumaki, Mitsuru Horiki, Junko Murai, et al.
Pharmacology & Therapeutics
|
May 26, 2019
Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies
Junko Murai, Anish Thomas, Markku Miettinen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 31, 2020
Response to Letter to the Editor by Yang et al
Raffit Hassan, Manjistha Sengupta, Junko Murai, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 4, 2006
Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development
Mina Okamoto, Junko Murai, Hideki Yoshikawa, et al.
Page
of 8